Sanchem Life Science

Sanchem Life Science is committed to delivering high-quality pharmaceutical and healthcare products with a focus on innovation, quality, and customer satisfaction. We strive to provide reliable solutions that meet global healthcare standards.

Intrinsicly evisculate emerging cutting edge scenarios redefine future-proof e-markets demand line

Gallery Posts

delivery Trusted pharmaceutical solutions for every stage of life

customer-service Need Help? +91 9811494850

Novanift-100 (Nitrofurantoin 100mg SR Tablets)

  • Home
  • Product
  • Novanift-100 (Nitrofurantoin 100mg SR Tablets)

Novanift-100 (Nitrofurantoin 100mg SR Tablets)

Novanift-100 is a sustained-release (SR) tablet formulation from Sanchem containing Nitrofurantoin 100mg, a urinary antiseptic antibiotic widely used for the treatment and prevention of uncomplicated urinary tract infections (UTIs). Nitrofurantoin works by concentrating in the urine, where it disrupts bacterial enzyme systems responsible for cell wall synthesis, DNA replication, and other essential metabolic processes, making it bactericidal against many common uropathogens.


Description

Understanding Novanift-100

Novanift-100 is a sustained-release tablet formulation containing Nitrofurantoin 100mg, manufactured by Sanchem. Nitrofurantoin is one of the most established and widely used urinary antiseptics, valued for its targeted action within the urinary tract and its continued effectiveness against many common uropathogens even as resistance to other antibiotic classes has grown.

How It Works

Nitrofurantoin is unique among antibiotics in that its activity depends on being reduced by bacterial flavoproteins into highly reactive intermediates within the bacterial cell. These reactive compounds attack multiple bacterial targets simultaneously — including ribosomal proteins, DNA, RNA, and cell wall components — which disrupts several essential metabolic pathways at once. This multi-target mechanism is thought to be one reason bacterial resistance to nitrofurantoin has remained relatively uncommon compared to antibiotics with a single mechanism of action.

Because the drug is rapidly excreted by the kidneys and concentrates significantly in urine relative to blood, it achieves high local concentrations in the urinary tract while systemic levels remain low. This is why Nitrofurantoin is effective specifically for urinary tract infections but is not suitable for treating infections elsewhere in the body.

Common Areas of Use

Novanift-100 SR is commonly prescribed for:

  • Acute uncomplicated cystitis (bladder infections) caused by susceptible organisms, most commonly E. coli
  • Prevention (prophylaxis) of recurrent urinary tract infections, often used long-term at lower doses in patients with frequent UTIs
  • Short-term prophylaxis in patients undergoing certain urological procedures, as directed by a physician

It is generally not used for kidney infections (pyelonephritis), prostatitis, or infections outside the urinary tract, as it doesn't reach effective concentrations in those tissues.

Dosage and Administration

Dosage and duration should be determined by a physician based on the indication (acute treatment vs. prophylaxis), the patient's renal function, age, and clinical response. The sustained-release formulation should generally be taken with food, which improves absorption and helps minimize gastrointestinal side effects such as nausea. Tablets should be swallowed whole and not crushed or chewed unless a physician specifically advises otherwise.

Patients should complete the full prescribed course even if symptoms resolve early, to reduce the risk of incomplete treatment and recurrence.

Safety Information

Before starting Novanift-100, patients should inform their doctor of:

  • Any known allergy to nitrofurantoin or related compounds
  • Kidney function status, since Nitrofurantoin is contraindicated in significant renal impairment (reduced clearance can lead to toxic accumulation while also reducing urinary concentration needed for efficacy)
  • Pregnancy status, particularly near-term pregnancy (contraindicated at 38–42 weeks gestation due to risk of hemolytic anemia in the newborn)
  • G6PD deficiency, as Nitrofurantoin can trigger hemolytic anemia in G6PD-deficient individuals
  • Any history of pulmonary, hepatic, or peripheral neuropathy issues, since rare but serious pulmonary and hepatic reactions have been associated with prolonged nitrofurantoin use, particularly with long-term prophylactic use
  • All other medications being taken, to check for interactions

Patients on long-term prophylactic therapy should have periodic monitoring as advised by their physician, given the association between prolonged use and rare pulmonary or hepatic effects.

Novanift-100 should be stored in a cool, dry place away from direct sunlight and moisture, and kept out of reach of children.

Quality You Can Trust

Every batch of Novanift-100 is manufactured in a GMP-compliant facility, with rigorous quality control testing at each stage to ensure consistent potency, purity, and dissolution performance appropriate to its sustained-release design.

Why Choose Sanchem's Novanift-100

Novanift-100 reflects Sanchem's commitment to providing reliable, well-manufactured antimicrobial therapies, developed and tested under strict quality standards to support physicians in managing urinary tract infections effectively.

A Note for Healthcare Professionals

Sanchem welcomes healthcare providers to reach out for detailed prescribing information, susceptibility data, and dosing guidelines relevant to Novanift-100.